Late Breaking Abstract - Patients with Severe Eosinophilic Asthma Achieved Remission over 2 Years with Benralizumab: Integrated Analysis of the ≫1000-Patient, Multinational, Real-World Xaloc-1 Study
                        AuthID
P-00Z-QRE
                
    P-00Z-QRE